Kortikoid

Triamcinolone Acetonide, the active ingredient in Kortikoid, is a corticosteroid presented as a topical formulation for skin use. It treats inflammatory and allergic skin conditions such as atopic dermatitis, contact dermatitis, psoriasis, eczema and other allergic reactions.

GNH USA supplies Kortikoid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kortikoid (triamcinolone acetonide) is employed to manage inflammatory skin disorders by reducing inflammation and immune activity. - Atopic dermatitis: alleviates redness, itching and swelling. - Contact dermatitis: diminishes allergic skin reactions and irritation. - Psoriasis: reduces plaque formation and scaling. - Eczema: controls flare‑ups and improves skin barrier. - Allergic skin reactions: suppresses hypersensitivity responses.

Kortikoid may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Burning or stinging at the application site. - Skin dryness or flaking. - Pruritus or mild irritation. - Folliculitis or acneiform eruptions. - Erythema or mild redness.

Serious or Rare Side Effects: - Skin atrophy or thinning. - Telangiectasia (visible small blood vessels). - Hypersensitivity reactions including contact dermatitis. - Secondary bacterial, fungal or viral skin infection. - Systemic adrenal suppression with extensive use. - Cushingoid features in extreme cases.

Before using Kortikoid, consider the following safety measures. - Pregnancy: safety not established; consult a physician before use. - Breastfeeding: unknown risk; weigh benefits against potential effects. - Children: limit duration and surface area; monitor for growth impact. - Infected skin: avoid application on active bacterial, viral or fungal infections. - Occlusive dressings: do not cover treated area unless directed by a clinician. - Store at room temperature: keep in the original container, protect from moisture and light.

Kortikoid can interact with other medicines; some require avoidance while others need monitoring.

Major Interactions (Avoid): - Systemic corticosteroids: may increase overall glucocorticoid exposure. - CYP3A4 inducers (e.g., rifampicin): may reduce local efficacy. - Azole antifungals: can raise local steroid concentration. - Live vaccines: systemic immunosuppression may diminish vaccine effectiveness.

Moderate Interactions (Monitor Closely): - NSAIDs applied to the same area: may heighten skin irritation. - Topical antibiotics: monitor for additive local reactions. - Herbal or over‑the‑counter skin products: assess for combined irritant potential.